Canada · Health Canada Drug Product Database

TRI-JORDYNA 21

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 97651
DIN: 02486296
Form: Tablet
Company as listed by source: GLENMARK PHARMACEUTICALS CANADA INC.
Source status: Marketed (2020-07-08)
Source last updated: 2025-09-17

Source-listed ingredients

NORGESTIMATE — 0.18 MG
ETHINYL ESTRADIOL — 0.035 MG
NORGESTIMATE — 0.215 MG
ETHINYL ESTRADIOL — 0.035 MG
NORGESTIMATE — 0.25 MG
ETHINYL ESTRADIOL — 0.035 MG

These values do not establish equivalence or a dose recommendation.

Packages

63 Tabs (3 X 21)

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →